Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 102351-102400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04415983
Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
PHASE3Recruiting
100 participants
Started: Jun 1, 2020 · Completed: Dec 1, 2030
1 condition1 sponsor1 location
NCT04201015
Optimising Pacing for Contractility 2
PHASE2/PHASE3Recruiting
400 participants
Started: Jun 1, 2020 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT04599764
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease
NARecruiting
60 participants
Started: Jun 1, 2020 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT04291352
Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation
NARecruiting
60 participants
Started: Jun 1, 2020 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04359238
activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch
NARecruiting
300 participants
Started: Jun 1, 2020 · Completed: Jun 1, 2024
2 conditions7 sponsors1 location
NCT04556214
Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)
NARecruiting
15 participants
Started: Jun 1, 2020 · Completed: May 31, 2035
1 condition1 sponsor1 location
NCT03481205
Ischemic Conditioning During Air tRansport Save penUmbral Tissue
NARecruiting
10 participants
Started: Jun 1, 2020 · Completed: Apr 1, 2025
1 condition1 sponsor1 location
NCT06226831
Onset of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients
N/ARecruiting
1,500 participants
Started: Jun 1, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05831826
Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China
N/ARecruiting
1,200 participants
Started: Jun 1, 2020 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT03917173
Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study
NARecruiting
240 participants
Started: Jun 1, 2020 · Completed: Jun 1, 2025
1 condition1 sponsor13 locations
NCT04602481
COVID-19 in People With Primary Ciliary Dyskinesia
N/ARecruiting
1,000 participants
Started: May 31, 2020 · Completed: May 31, 2030
1 condition12 sponsors1 location
NCT04296903
Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)
NAActive, not recruiting
201 participants
Started: May 31, 2020 · Completed: Jun 30, 2030
1 condition1 sponsor14 locations
NCT05959603
Intra-wound Vancomycin Powder for Prevention of Surgical Site Infection Following Spinal Surgery
PHASE3Recruiting
363 participants
Started: May 31, 2020 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT03991806
Association of Centre of Excellence Self- Administered Questionnaire Score and Frailty Levels
N/AActive, not recruiting
30,000 participants
Started: May 31, 2020 · Completed: Aug 31, 2025
4 conditions1 sponsor1 location
NCT04751084
Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment
NAActive, not recruiting
675 participants
Started: May 30, 2020 · Completed: Sep 14, 2024
2 conditions1 sponsor1 location
NCT04405635
Quantifying Digital Behavior on Smart Phones - Data From Stroke Survivors
N/ARecruiting
50 participants
Started: May 30, 2020 · Completed: Aug 30, 2024
1 condition3 sponsors1 location
NCT04764227
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
PHASE2Active, not recruiting
70 participants
Started: May 30, 2020 · Completed: Mar 30, 2027
5 conditions1 sponsor1 location
NCT04398914
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
PHASE2Active, not recruiting
216 participants
Started: May 30, 2020 · Completed: Dec 30, 2027
1 condition2 sponsors1 location
NCT03973671
Prospective Sample Collection for Cancer of Bladder
N/ARecruiting
300 participants
Started: May 29, 2020 · Completed: May 31, 2032
1 condition2 sponsors1 location
NCT04715399
UPenn Observational Research Repository on Neurodegenerative Disease
N/ARecruiting
1,000 participants
Started: May 29, 2020 · Completed: May 30, 2070
9 conditions5 sponsors1 location
NCT04495660
Restauration of the Auditory and Cognitive Functions in Cochlear Implanted Deaf Children in FNIRS
NARecruiting
80 participants
Started: May 29, 2020 · Completed: Jun 3, 2026
1 condition1 sponsor1 location
NCT04379635
Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)
PHASE3Active, not recruiting
453 participants
Started: May 29, 2020 · Completed: Oct 31, 2025
1 condition1 sponsor44 locations
NCT04174391
Lifestyles and Breast Cancer
NAActive, not recruiting
766 participants
Started: May 29, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors4 locations
NCT04268199
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
PHASE2Recruiting
100 participants
Started: May 29, 2020 · Completed: May 31, 2025
2 conditions2 sponsors2 locations
NCT04318717
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
PHASE2Recruiting
16 participants
Started: May 29, 2020 · Completed: Feb 12, 2029
1 condition1 sponsor1 location
NCT04216524
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
PHASE2Recruiting
40 participants
Started: May 29, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04397211
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease
NAActive, not recruiting
1,872 participants
Started: May 29, 2020 · Completed: Sep 30, 2028
1 condition23 sponsors23 locations
NCT04378855
Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).
N/AActive, not recruiting
572 participants
Started: May 29, 2020 · Completed: Nov 15, 2025
1 condition1 sponsor25 locations
NCT04575337
Study on Biomarkers for Early Diagnosis of Alzheimer's Disease
N/ARecruiting
6,000 participants
Started: May 28, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04410796
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
PHASE2Recruiting
571 participants
Started: May 28, 2020 · Completed: May 31, 2026
1 condition3 sponsors18 locations
NCT04057898
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
PHASE2/PHASE3Active, not recruiting
234 participants
Started: May 28, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor16 locations
NCT05731752
Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
80 participants
Started: May 28, 2020 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT04496973
University of Delaware Parkinson's Disease Registry
N/ARecruiting
1,000 participants
Started: May 28, 2020 · Completed: Jan 1, 2030
1 condition1 sponsor1 location
NCT06815172
PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.
N/AActive, not recruiting
500 participants
Started: May 28, 2020 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT04117087
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
PHASE1Active, not recruiting
27 participants
Started: May 28, 2020 · Completed: Jun 1, 2027
2 conditions4 sponsors1 location
NCT04396821
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
150 participants
Started: May 28, 2020 · Completed: Sep 30, 2025
4 conditions2 sponsors18 locations
NCT04455438
SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions
NARecruiting
15 participants
Started: May 28, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04297085
Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence
NARecruiting
3,400 participants
Started: May 28, 2020 · Completed: Apr 30, 2050
1 condition1 sponsor4 locations
NCT04492293
An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer
PHASE2Recruiting
115 participants
Started: May 27, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor22 locations
NCT04211935
Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum
NARecruiting
158 participants
Started: May 27, 2020 · Completed: Jun 30, 2024
2 conditions2 sponsors1 location
NCT04128748
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
PHASE1/PHASE2Recruiting
52 participants
Started: May 27, 2020 · Completed: Dec 31, 2025
7 conditions2 sponsors1 location
NCT04396327
SM-1 vs. an Active Comparator in A Model of Transient Insomnia
PHASE2Not yet recruiting
14 participants
Started: May 27, 2020 · Completed: Jun 30, 2020
1 condition1 sponsor1 location
NCT04362839
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
PHASE1Active, not recruiting
39 participants
Started: May 27, 2020 · Completed: Jan 12, 2026
25 conditions2 sponsors1 location
NCT02982902
T Cell Therapy of Opportunistic Cytomegalovirus Infection
EARLY_PHASE1Recruiting
20 participants
Started: May 27, 2020 · Completed: Aug 31, 2028
3 conditions1 sponsor1 location
NCT05778474
Mechanical Determinants of Upper Limbs Oscillation During Gait
N/ARecruiting
25 participants
Started: May 27, 2020 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT04325217
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
N/AActive, not recruiting
586 participants
Started: May 27, 2020 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04462159
The Young Heart Study
NAActive, not recruiting
60 participants
Started: May 27, 2020 · Completed: May 27, 2026
2 conditions1 sponsor1 location
NCT05789667
Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
N/ARecruiting
50 participants
Started: May 27, 2020 · Completed: Dec 31, 2025
2 conditions8 sponsors1 location
NCT04421924
Periinterventional Coagulation Management of Patients Undergoing a TIPS
NARecruiting
39 participants
Started: May 27, 2020 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT06084299
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer
PHASE1Recruiting
16 participants
Started: May 27, 2020 · Completed: Aug 30, 2026
1 condition2 sponsors1 location